Teladoc (NYSE:TDOC) shares popped 8.5% in after-hours trading after the company raised the lower end of its full-year forecast.
The company now sees full-year revenue at $2.64 billion (the midpoint of the provided range), up from the prior forecast and guidance of $2.63B. Teladoc also sees a loss per share of $1.25-1.60, better than the prior forecast for a loss per share of $1.25-1.70.
For this quarter, the company sees a loss per share of $0.45 on revenue of $662.5 million, which compares to the consensus for a loss per share of $0.33 on revenue of $664M.
As far as the second quarter is concerned, revenue rose 10% to $652.4M, topping the consensus of $649.2M. A loss per share came in at $0.40, somewhere in line with the consensus for a loss per share of $0.41.
"This performance is a direct result of introducing and expanding new products and services, investing in a robust innovation pipeline, controlling expenses, and vertically integrating care to capitalize on customer demand for unified virtual and in-person healthcare experiences," the company said in a release.